EXAS vs MNTN · rev $2.76B vs rev $290.1M
EXACT Sciences Corporation (EXAS) versus MNTN, Inc. (MNTN) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
MNTN, Inc. (MNTN) is a software - application company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MNTN revenue for 2025-12-31 was $290.1M. Net income was -$6.4M. Revenue was up 28.6% from 2024-12-31 to 2025-12-31. MNTN currently screens at market cap $0.
EXAS currently screens at market cap $20.03B. MNTN currently screens at market cap $0.
Not investment advice. Open the EXAS and MNTN stock pages for the full models.
Not investment advice.